+关注
ikarishingi
暂无个人介绍
IP属地:未知
5
关注
0
粉丝
0
主题
0
勋章
主贴
热门
ikarishingi
2021-10-23
Tesla to the moon
Tesla Stock Closed Above $900 for First Time. What Could Come Next.<blockquote>特斯拉股价首次收于 900 美元以上。接下来会发生什么。</blockquote>
ikarishingi
2021-10-22
What a drastic droo
抱歉,原内容已删除
ikarishingi
2021-03-19
Tesla to the moon
Is This Underappreciated Cathie Wood Stock a Better Buy Than Tesla Right Now?<blockquote>这只被低估的凯西伍德股票现在比特斯拉更值得购买吗?</blockquote>
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3576884931619523","uuid":"3576884931619523","gmtCreate":1613790907707,"gmtModify":1616164535732,"name":"ikarishingi","pinyin":"ikarishingi","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/3d2e9e96320a649321b1565cb688a7dd","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":5,"tweetSize":3,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.08.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.03.13","exceedPercentage":"60.55%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.10.10","exceedPercentage":"80.13%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.05.10","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":858088875,"gmtCreate":1634953290793,"gmtModify":1634954241447,"author":{"id":"3576884931619523","authorId":"3576884931619523","name":"ikarishingi","avatar":"https://static.tigerbbs.com/3d2e9e96320a649321b1565cb688a7dd","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576884931619523","idStr":"3576884931619523"},"themes":[],"title":"","htmlText":"Tesla to the moon","listText":"Tesla to the moon","text":"Tesla to the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/858088875","repostId":"1166213725","repostType":4,"repost":{"id":"1166213725","kind":"news","pubTimestamp":1634948473,"share":"https://www.laohunote.com/m/news/1166213725?lang=zh_CN&edition=full","pubTime":"2021-10-23 08:21","market":"us","language":"en","title":"Tesla Stock Closed Above $900 for First Time. What Could Come Next.<blockquote>特斯拉股价首次收于 900 美元以上。接下来会发生什么。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1166213725","media":"Barrons","summary":"Tesla stock hit a new all-time high in Friday trading, and closed at a record. The stock’s recent run has been incredible. How high can it go?Tesla stock closed at $909.68, up about 1.8%. The S&P 500 dropped about 0.1%, while the Dow Jones Industrial Average added about 0.2%.Shares of the electric-vehicle giant have been boosted by strong deliveries and earnings. Shares also got a boost Friday from a credit upgrade at S&P. Tesla debt is now BB+ rated, one notch below investment grade.Tesla stoc","content":"<p>Tesla stock hit a new all-time high in Friday trading, and closed at a record. The stock’s recent run has been incredible. How high can it go?</p><p><blockquote>特斯拉股价在周五交易中创下历史新高,并以历史新高收盘。该股最近的表现令人难以置信。能升到多高?</blockquote></p><p> Tesla (ticker: TSLA) stock closed at $909.68, up about 1.8%. The S&P 500 dropped about 0.1%, while the Dow Jones Industrial Average added about 0.2%.</p><p><blockquote>特斯拉(股票代码:TSLA)股价收于909.68美元,上涨约1.8%。标普500下跌约0.1%,道琼斯工业平均指数上涨约0.2%。</blockquote></p><p> Shares of the electric-vehicle giant have been boosted by strong deliveries and earnings. Shares also got a boost Friday from a credit upgrade at S&P. Tesla debt is now BB+ rated, one notch below investment grade.</p><p><blockquote>强劲的交付量和盈利提振了这家电动汽车巨头的股价。周五,标准普尔信用评级上调也提振了股价。特斯拉债务目前的评级为 BB+,比投资级别低一级。</blockquote></p><p> Tesla stock’s new 52-week intraday high is $910 on the nose. The old high-water mark of $900.40 was set on Jan. 25, according to Dow Jones Market Data. On Thursday, Tesla closed at a record for the first time since Jan. 26.</p><p><blockquote>特斯拉股市盘中新高 910 美元即将创下 52 周新高。根据道琼斯市场数据,900.40美元的旧高点是在1月25日创下的。周四,特斯拉自1月26日以来首次创下历史新高。</blockquote></p><p> Shares are up about 40% over the past three months, pushing the market cap to roughly $910 billion. (Tesla has about 1 billion shares outstanding, making the math easy.)</p><p><blockquote>过去三个月,该股上涨了约 40%,市值达到约 9,100 亿美元。(特斯拉约有 10 亿股流通股,计算起来很容易。)</blockquote></p><p> Bulls, naturally, see more gains ahead. Wedbush analyst Dan Ives raised his bull-case Tesla stock price target to $1,500 from $1,300 after the company reported better-than-expected earnings on Wednesday.</p><p><blockquote>多头自然会看到更多涨幅。Wedbush 分析师 Dan Ives 将特斯拉股价目标从 1,300 美元上调至 1,500 美元,此前该公司周三公布了好于预期的收益。</blockquote></p><p> “Tesla is rising because earnings revisions are soaring,” points out Gary Black, managing partner of the Future Fund Active exchange-traded fund. Analyst estimates for Tesla’s 2022 earnings have risen to about $8 a share from $6 over the past few weeks. “Rising estimates drove Tesla to the moon in 2020. They will drive Tesla to $1,000-plus in 2022,” Black says.</p><p><blockquote>“Future Fund Active exchange-traded Fund 的执行合伙人 Gary Black 指出:”特斯拉之所以上升,是因为盈利修正幅度在飙升。过去几周,分析师对特斯拉 2022 年盈利的预期已从每股 6 美元上升到约 8 美元。“不断上升的估计将特斯拉推上了 2020 年的月球。它们将推动特斯拉在 2022 年达到 1000 美元以上,”布莱克说。</blockquote></p><p> Ives rates Tesla stock Buy, and Tesla is the largest position in Black’s fund.</p><p><blockquote>艾夫斯将特斯拉股票评级为买入,特斯拉是布莱克基金中最大的仓位。</blockquote></p><p> Yes, there are still Tesla bears out there who believe the stock is overvalued. The bottom third of analyst price targets averages about $425, less than half of Friday’s close.</p><p><blockquote>是的,仍然有特斯拉空头认为该股被高估了。分析师目标价的倒数三分之一平均约为 425 美元,不到周五收盘价的一半。</blockquote></p><p> Bears expect the sky-high valuation to give investors pause eventually. Stocks don’t usually fall just because investors, collectively, wake up one morning and feel differently about valuation. Something has to happen. The overall market could tumble, or the business could trip up. Analysts expect Tesla deliveries to grow to 1.3 million units in 2022 from about 890,000 units in 2021. Any hiccup to growth would be a negative catalyst for shares.</p><p><blockquote>看空者预计天价估值最终会让投资者犹豫不决。股票下跌通常不会仅仅因为投资者一天早上醒来对估值有不同的看法。总得有点事发生。整体市场可能会暴跌,或者业务可能会陷入困境。分析师预计特斯拉交付量将从 2021 年的约 89 万辆增长至 2022 年的 130 万辆。增长的任何挫折都将成为股市的负面催化剂。</blockquote></p><p> Whether the stock rises or falls in the short run is anyone’s guess. For now, though, the momentum belongs to Tesla bulls.</p><p><blockquote>该股短期内是上涨还是下跌谁也说不准。不过,就目前而言,势头属于特斯拉多头。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Stock Closed Above $900 for First Time. What Could Come Next.<blockquote>特斯拉股价首次收于 900 美元以上。接下来会发生什么。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Stock Closed Above $900 for First Time. What Could Come Next.<blockquote>特斯拉股价首次收于 900 美元以上。接下来会发生什么。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-10-23 08:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Tesla stock hit a new all-time high in Friday trading, and closed at a record. The stock’s recent run has been incredible. How high can it go?</p><p><blockquote>特斯拉股价在周五交易中创下历史新高,并以历史新高收盘。该股最近的表现令人难以置信。能升到多高?</blockquote></p><p> Tesla (ticker: TSLA) stock closed at $909.68, up about 1.8%. The S&P 500 dropped about 0.1%, while the Dow Jones Industrial Average added about 0.2%.</p><p><blockquote>特斯拉(股票代码:TSLA)股价收于909.68美元,上涨约1.8%。标普500下跌约0.1%,道琼斯工业平均指数上涨约0.2%。</blockquote></p><p> Shares of the electric-vehicle giant have been boosted by strong deliveries and earnings. Shares also got a boost Friday from a credit upgrade at S&P. Tesla debt is now BB+ rated, one notch below investment grade.</p><p><blockquote>强劲的交付量和盈利提振了这家电动汽车巨头的股价。周五,标准普尔信用评级上调也提振了股价。特斯拉债务目前的评级为 BB+,比投资级别低一级。</blockquote></p><p> Tesla stock’s new 52-week intraday high is $910 on the nose. The old high-water mark of $900.40 was set on Jan. 25, according to Dow Jones Market Data. On Thursday, Tesla closed at a record for the first time since Jan. 26.</p><p><blockquote>特斯拉股市盘中新高 910 美元即将创下 52 周新高。根据道琼斯市场数据,900.40美元的旧高点是在1月25日创下的。周四,特斯拉自1月26日以来首次创下历史新高。</blockquote></p><p> Shares are up about 40% over the past three months, pushing the market cap to roughly $910 billion. (Tesla has about 1 billion shares outstanding, making the math easy.)</p><p><blockquote>过去三个月,该股上涨了约 40%,市值达到约 9,100 亿美元。(特斯拉约有 10 亿股流通股,计算起来很容易。)</blockquote></p><p> Bulls, naturally, see more gains ahead. Wedbush analyst Dan Ives raised his bull-case Tesla stock price target to $1,500 from $1,300 after the company reported better-than-expected earnings on Wednesday.</p><p><blockquote>多头自然会看到更多涨幅。Wedbush 分析师 Dan Ives 将特斯拉股价目标从 1,300 美元上调至 1,500 美元,此前该公司周三公布了好于预期的收益。</blockquote></p><p> “Tesla is rising because earnings revisions are soaring,” points out Gary Black, managing partner of the Future Fund Active exchange-traded fund. Analyst estimates for Tesla’s 2022 earnings have risen to about $8 a share from $6 over the past few weeks. “Rising estimates drove Tesla to the moon in 2020. They will drive Tesla to $1,000-plus in 2022,” Black says.</p><p><blockquote>“Future Fund Active exchange-traded Fund 的执行合伙人 Gary Black 指出:”特斯拉之所以上升,是因为盈利修正幅度在飙升。过去几周,分析师对特斯拉 2022 年盈利的预期已从每股 6 美元上升到约 8 美元。“不断上升的估计将特斯拉推上了 2020 年的月球。它们将推动特斯拉在 2022 年达到 1000 美元以上,”布莱克说。</blockquote></p><p> Ives rates Tesla stock Buy, and Tesla is the largest position in Black’s fund.</p><p><blockquote>艾夫斯将特斯拉股票评级为买入,特斯拉是布莱克基金中最大的仓位。</blockquote></p><p> Yes, there are still Tesla bears out there who believe the stock is overvalued. The bottom third of analyst price targets averages about $425, less than half of Friday’s close.</p><p><blockquote>是的,仍然有特斯拉空头认为该股被高估了。分析师目标价的倒数三分之一平均约为 425 美元,不到周五收盘价的一半。</blockquote></p><p> Bears expect the sky-high valuation to give investors pause eventually. Stocks don’t usually fall just because investors, collectively, wake up one morning and feel differently about valuation. Something has to happen. The overall market could tumble, or the business could trip up. Analysts expect Tesla deliveries to grow to 1.3 million units in 2022 from about 890,000 units in 2021. Any hiccup to growth would be a negative catalyst for shares.</p><p><blockquote>看空者预计天价估值最终会让投资者犹豫不决。股票下跌通常不会仅仅因为投资者一天早上醒来对估值有不同的看法。总得有点事发生。整体市场可能会暴跌,或者业务可能会陷入困境。分析师预计特斯拉交付量将从 2021 年的约 89 万辆增长至 2022 年的 130 万辆。增长的任何挫折都将成为股市的负面催化剂。</blockquote></p><p> Whether the stock rises or falls in the short run is anyone’s guess. For now, though, the momentum belongs to Tesla bulls.</p><p><blockquote>该股短期内是上涨还是下跌谁也说不准。不过,就目前而言,势头属于特斯拉多头。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.barrons.com/articles/tesla-stock-record-high-51634913773?mod=hp_LATEST\">Barrons</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.barrons.com/articles/tesla-stock-record-high-51634913773?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166213725","content_text":"Tesla stock hit a new all-time high in Friday trading, and closed at a record. The stock’s recent run has been incredible. How high can it go?\nTesla (ticker: TSLA) stock closed at $909.68, up about 1.8%. The S&P 500 dropped about 0.1%, while the Dow Jones Industrial Average added about 0.2%.\nShares of the electric-vehicle giant have been boosted by strong deliveries and earnings. Shares also got a boost Friday from a credit upgrade at S&P. Tesla debt is now BB+ rated, one notch below investment grade.\nTesla stock’s new 52-week intraday high is $910 on the nose. The old high-water mark of $900.40 was set on Jan. 25, according to Dow Jones Market Data. On Thursday, Tesla closed at a record for the first time since Jan. 26.\nShares are up about 40% over the past three months, pushing the market cap to roughly $910 billion. (Tesla has about 1 billion shares outstanding, making the math easy.)\nBulls, naturally, see more gains ahead. Wedbush analyst Dan Ives raised his bull-case Tesla stock price target to $1,500 from $1,300 after the company reported better-than-expected earnings on Wednesday.\n“Tesla is rising because earnings revisions are soaring,” points out Gary Black, managing partner of the Future Fund Active exchange-traded fund. Analyst estimates for Tesla’s 2022 earnings have risen to about $8 a share from $6 over the past few weeks. “Rising estimates drove Tesla to the moon in 2020. They will drive Tesla to $1,000-plus in 2022,” Black says.\nIves rates Tesla stock Buy, and Tesla is the largest position in Black’s fund.\nYes, there are still Tesla bears out there who believe the stock is overvalued. The bottom third of analyst price targets averages about $425, less than half of Friday’s close.\nBears expect the sky-high valuation to give investors pause eventually. Stocks don’t usually fall just because investors, collectively, wake up one morning and feel differently about valuation. Something has to happen. The overall market could tumble, or the business could trip up. Analysts expect Tesla deliveries to grow to 1.3 million units in 2022 from about 890,000 units in 2021. Any hiccup to growth would be a negative catalyst for shares.\nWhether the stock rises or falls in the short run is anyone’s guess. For now, though, the momentum belongs to Tesla bulls.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":648,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":851090164,"gmtCreate":1634857328674,"gmtModify":1634857328782,"author":{"id":"3576884931619523","authorId":"3576884931619523","name":"ikarishingi","avatar":"https://static.tigerbbs.com/3d2e9e96320a649321b1565cb688a7dd","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576884931619523","idStr":"3576884931619523"},"themes":[],"title":"","htmlText":"What a drastic droo","listText":"What a drastic droo","text":"What a drastic droo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/851090164","repostId":"2177640184","repostType":4,"isVote":1,"tweetType":1,"viewCount":592,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":350945833,"gmtCreate":1616155073822,"gmtModify":1634526972633,"author":{"id":"3576884931619523","authorId":"3576884931619523","name":"ikarishingi","avatar":"https://static.tigerbbs.com/3d2e9e96320a649321b1565cb688a7dd","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576884931619523","idStr":"3576884931619523"},"themes":[],"title":"","htmlText":"Tesla to the moon","listText":"Tesla to the moon","text":"Tesla to the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/350945833","repostId":"1197074607","repostType":4,"repost":{"id":"1197074607","kind":"news","pubTimestamp":1616152229,"share":"https://www.laohunote.com/m/news/1197074607?lang=zh_CN&edition=full","pubTime":"2021-03-19 19:10","market":"us","language":"en","title":"Is This Underappreciated Cathie Wood Stock a Better Buy Than Tesla Right Now?<blockquote>这只被低估的凯西伍德股票现在比特斯拉更值得购买吗?</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1197074607","media":"Motley Fool","summary":"It definitely could have more upside potential.Pretty much everybody knows Cathie Wood really likesT","content":"<p>It definitely could have more upside potential.Pretty much everybody knows Cathie Wood really likes<b>Tesla</b>(NASDAQ:TSLA). The ARK Investment Management founder and CEO talks about Tesla regularly. And when the electric-vehicle stock dips, Wood usually buys even more for her high-flying exchange-traded funds.</p><p><blockquote>它肯定有更多的上涨潜力。几乎每个人都知道凯茜·伍德真的很喜欢<b>特斯拉</b>(纳斯达克股票代码:TSLA)方舟投资管理公司的创始人兼首席执行官经常谈论特斯拉。当电动汽车股票下跌时,伍德通常会为她飞涨的交易所交易基金买入更多。</blockquote></p><p>Many of the other holdings in the ETFs managed by Wood don't receive as much attention. However, she pointed to one of them earlier this month in a CNBC interview, referring to it as one of the \"most underappreciated\" stocks that she owns.</p><p><blockquote>伍德管理的 ETF 中的许多其他持股并没有受到太多关注。然而,她在本月早些时候接受 CNBC 采访时指出了其中一只股票,称其为她拥有的“最被低估”的股票之一。</blockquote></p><p>What is this underappreciated stock -- and could it be an even better buy than Tesla?</p><p><blockquote>这只被低估的股票是什么——它会比特斯拉更值得购买吗?</blockquote></p><p><b>It's in the genes</b></p><p><blockquote><b>这是基因里的</b></blockquote></p><p>Wood singled out medical genetics leader<b>Invitae</b>(NYSE:NVTA)as an especially underappreciated stock. The company states that its mission \"is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.\"</p><p><blockquote>伍德挑选出医学遗传学领导者<b>邀请</b>(纽约证券交易所股票代码:NVTA)作为一只特别被低估的股票。该公司表示,其使命“是将全面的基因信息引入主流医学,以改善数十亿人的医疗保健。”</blockquote></p><p>That's the kind of ambitious goal that excites Cathie Wood. It's not surprising, therefore, that two of the ETFs that she manages have positions in Invitae. The stock is the 11th-largest holding in the<b>ARK Innovation ETF</b>and the 17th-largest holding in the<b>ARK Genomic Revolution ETF</b>.</p><p><blockquote>这就是让凯西·伍德兴奋的雄心勃勃的目标。因此,她管理的两只 ETF 持有 Invitae 头寸也就不足为奇了。该股是美国第 11 大持股<b>方舟创新ETF</b>以及第 17 大持股<b>方舟基因组革命 ETF</b>.</blockquote></p><p>Invitae offers a wide range of genetic testing. Individuals can determine their risks of passing on genetic conditions to children and the most suitable embryos to help ensure a healthy pregnancy can be identified during in vitro fertilization. Healthcare providers can order genetic diagnostics tests for an extensive and growing list of conditions.</p><p><blockquote>Invitae提供广泛的基因检测。个人可以确定他们将遗传疾病传递给孩子的风险,并在体外受精期间确定最合适的胚胎,以帮助确保健康怀孕。医疗保健提供者可以为越来越多的疾病订购基因诊断测试。</blockquote></p><p>Over the last five years, Invitae's trailing-12-month revenue has skyrocketed over 2,400%. That performance trounces Tesla's revenue growth of around 640% during the same period.</p><p><blockquote>在过去五年中,Invitae 过去 12 个月的收入飙升了 2,400% 以上。这一业绩超过了特斯拉同期约 640% 的收入增长。</blockquote></p><p>Unlike Tesla, however, Invitae isn't profitable yet. But the genetic testing companyhas a path to profitabilityover the next few years, especially with the recent acquisitions of ArcherDX and One Codex expanding Invitae's capabilities.</p><p><blockquote>然而,与特斯拉不同的是,Invitae 尚未盈利。但这家基因检测公司在未来几年有一条实现盈利的道路,特别是最近收购了 ArcherDX 和 One Codex 扩展了 Invitae 的能力。</blockquote></p><p><b>A massive potential market</b></p><p><blockquote><b>巨大的潜在市场</b></blockquote></p><p>In the past, the high costs of genetic testing served as a limiting factor for growth in the market. But technological innovations in gene sequencing have reduced the costs of testing and opened the door to a massive potential market.</p><p><blockquote>过去,基因检测的高昂成本是市场增长的限制因素。但基因测序的技术创新降低了检测成本,并为巨大的潜在市场打开了大门。</blockquote></p><p>Invitae CEO Sean George told CNBC last week that the scenario for genetic testing is similar to what happened in the computing and networking industry around four decades ago. Lower semiconductor costs back then set the stage for an explosion in the market.</p><p><blockquote>Invitae 首席执行官肖恩·乔治 (Sean George) 上周告诉 CNBC,基因检测的场景与大约四十年前计算和网络行业发生的情况类似。半导体成本的下降为市场的爆炸式增长奠定了基础。</blockquote></p><p>How big could the explosion be in genetic testing? Invitae thinks that its total addressable market tops $150 billion annually. It projects that the genetic testing opportunity in senior adults ages 65 and over alone is around $63 billion. The company estimates that the potential genetic-testing market in adults between the ages of 41 and 65 totals around $60 billion.</p><p><blockquote>基因检测的爆炸会有多大?Invitae 认为其潜在市场总额每年超过 1500 亿美元。它预计,仅65岁及以上老年人的基因检测机会就约为630亿美元。该公司估计,41岁至65岁成年人的潜在基因检测市场总额约为600亿美元。</blockquote></p><p>Invitae believes that it's at an inflection point in the transformation curve for genetic testing. As the company continues to drive costs lower and expands its menu of tests, it expects testing volumes to increase significantly.</p><p><blockquote>Invitae认为,它正处于基因检测转型曲线的拐点。随着该公司继续降低成本并扩大测试菜单,预计测试量将大幅增加。</blockquote></p><p><b>Better than Tesla?</b></p><p><blockquote><b>比特斯拉好?</b></blockquote></p><p>To be sure, Invitae hasn't been as big of a winner as Tesla so far. Over the last five years, thehealthcare stockhas quintupled in value. During the same period, however, Tesla skyrocketed close to 1,500%.</p><p><blockquote>可以肯定的是,到目前为止,Invitae 还没有像特斯拉那样成为大赢家。过去五年,医疗保健股票的价值增长了五倍。然而,在同一时期,特斯拉飙升了近1500%。</blockquote></p><p>But could Invitae be a better pick than Tesla over the long run? When asked in a Bloomberg interview in December which stock could fuel the biggest gains for ARK ETFs over the next five years, Wood acknowledged that Tesla is in the running. However, she also stated, \"The biggest upside surprises are going to come from the genomics space.\"</p><p><blockquote>但从长远来看,Invitae会是比特斯拉更好的选择吗?当在去年 12 月接受彭博社采访时被问及哪只股票可以推动 ARK ETF 在未来五年内实现最大涨幅时,伍德承认特斯拉正在竞选之中。然而,她也表示,“最大的惊喜将来自基因组学领域。”</blockquote></p><p>That doesn't mean Invitae is necessarily the genomics stock that will emerge as the major surprise winner of the future. It could be, though.</p><p><blockquote>这并不意味着 Invitae 一定是基因组学股票,将成为未来的主要惊喜赢家。不过,也有可能。</blockquote></p><p>The company's market cap currently stands at only around $8.5 billion. Invitae could potentially be a 10-bagger if it snags a double-digit share of its addressable market. While Tesla has been remarkably successful, it's a stretch to envision the stock becoming a 10-bagger again.</p><p><blockquote>该公司目前的市值仅为85亿美元左右。如果 Invitae 在其潜在市场中占据两位数的份额,它可能会成为一个 10 袋生产商。虽然特斯拉取得了巨大成功,但很难想象该股再次成为 10 袋股票。</blockquote></p><p>Invitae just might be a better buy than Tesla right now. Even if it's not, though, there's a really good chance the stock won't remain underappreciated for too much longer.</p><p><blockquote>Invitae 目前可能比特斯拉更值得购买。不过,即使事实并非如此,该股也很有可能不会在更长时间内保持低估状态。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is This Underappreciated Cathie Wood Stock a Better Buy Than Tesla Right Now?<blockquote>这只被低估的凯西伍德股票现在比特斯拉更值得购买吗?</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs This Underappreciated Cathie Wood Stock a Better Buy Than Tesla Right Now?<blockquote>这只被低估的凯西伍德股票现在比特斯拉更值得购买吗?</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-03-19 19:10</span>\n</p>\n</h4>\n</header>\n<article>\n<p>It definitely could have more upside potential.Pretty much everybody knows Cathie Wood really likes<b>Tesla</b>(NASDAQ:TSLA). The ARK Investment Management founder and CEO talks about Tesla regularly. And when the electric-vehicle stock dips, Wood usually buys even more for her high-flying exchange-traded funds.</p><p><blockquote>它肯定有更多的上涨潜力。几乎每个人都知道凯茜·伍德真的很喜欢<b>特斯拉</b>(纳斯达克股票代码:TSLA)方舟投资管理公司的创始人兼首席执行官经常谈论特斯拉。当电动汽车股票下跌时,伍德通常会为她飞涨的交易所交易基金买入更多。</blockquote></p><p>Many of the other holdings in the ETFs managed by Wood don't receive as much attention. However, she pointed to one of them earlier this month in a CNBC interview, referring to it as one of the \"most underappreciated\" stocks that she owns.</p><p><blockquote>伍德管理的 ETF 中的许多其他持股并没有受到太多关注。然而,她在本月早些时候接受 CNBC 采访时指出了其中一只股票,称其为她拥有的“最被低估”的股票之一。</blockquote></p><p>What is this underappreciated stock -- and could it be an even better buy than Tesla?</p><p><blockquote>这只被低估的股票是什么——它会比特斯拉更值得购买吗?</blockquote></p><p><b>It's in the genes</b></p><p><blockquote><b>这是基因里的</b></blockquote></p><p>Wood singled out medical genetics leader<b>Invitae</b>(NYSE:NVTA)as an especially underappreciated stock. The company states that its mission \"is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.\"</p><p><blockquote>伍德挑选出医学遗传学领导者<b>邀请</b>(纽约证券交易所股票代码:NVTA)作为一只特别被低估的股票。该公司表示,其使命“是将全面的基因信息引入主流医学,以改善数十亿人的医疗保健。”</blockquote></p><p>That's the kind of ambitious goal that excites Cathie Wood. It's not surprising, therefore, that two of the ETFs that she manages have positions in Invitae. The stock is the 11th-largest holding in the<b>ARK Innovation ETF</b>and the 17th-largest holding in the<b>ARK Genomic Revolution ETF</b>.</p><p><blockquote>这就是让凯西·伍德兴奋的雄心勃勃的目标。因此,她管理的两只 ETF 持有 Invitae 头寸也就不足为奇了。该股是美国第 11 大持股<b>方舟创新ETF</b>以及第 17 大持股<b>方舟基因组革命 ETF</b>.</blockquote></p><p>Invitae offers a wide range of genetic testing. Individuals can determine their risks of passing on genetic conditions to children and the most suitable embryos to help ensure a healthy pregnancy can be identified during in vitro fertilization. Healthcare providers can order genetic diagnostics tests for an extensive and growing list of conditions.</p><p><blockquote>Invitae提供广泛的基因检测。个人可以确定他们将遗传疾病传递给孩子的风险,并在体外受精期间确定最合适的胚胎,以帮助确保健康怀孕。医疗保健提供者可以为越来越多的疾病订购基因诊断测试。</blockquote></p><p>Over the last five years, Invitae's trailing-12-month revenue has skyrocketed over 2,400%. That performance trounces Tesla's revenue growth of around 640% during the same period.</p><p><blockquote>在过去五年中,Invitae 过去 12 个月的收入飙升了 2,400% 以上。这一业绩超过了特斯拉同期约 640% 的收入增长。</blockquote></p><p>Unlike Tesla, however, Invitae isn't profitable yet. But the genetic testing companyhas a path to profitabilityover the next few years, especially with the recent acquisitions of ArcherDX and One Codex expanding Invitae's capabilities.</p><p><blockquote>然而,与特斯拉不同的是,Invitae 尚未盈利。但这家基因检测公司在未来几年有一条实现盈利的道路,特别是最近收购了 ArcherDX 和 One Codex 扩展了 Invitae 的能力。</blockquote></p><p><b>A massive potential market</b></p><p><blockquote><b>巨大的潜在市场</b></blockquote></p><p>In the past, the high costs of genetic testing served as a limiting factor for growth in the market. But technological innovations in gene sequencing have reduced the costs of testing and opened the door to a massive potential market.</p><p><blockquote>过去,基因检测的高昂成本是市场增长的限制因素。但基因测序的技术创新降低了检测成本,并为巨大的潜在市场打开了大门。</blockquote></p><p>Invitae CEO Sean George told CNBC last week that the scenario for genetic testing is similar to what happened in the computing and networking industry around four decades ago. Lower semiconductor costs back then set the stage for an explosion in the market.</p><p><blockquote>Invitae 首席执行官肖恩·乔治 (Sean George) 上周告诉 CNBC,基因检测的场景与大约四十年前计算和网络行业发生的情况类似。半导体成本的下降为市场的爆炸式增长奠定了基础。</blockquote></p><p>How big could the explosion be in genetic testing? Invitae thinks that its total addressable market tops $150 billion annually. It projects that the genetic testing opportunity in senior adults ages 65 and over alone is around $63 billion. The company estimates that the potential genetic-testing market in adults between the ages of 41 and 65 totals around $60 billion.</p><p><blockquote>基因检测的爆炸会有多大?Invitae 认为其潜在市场总额每年超过 1500 亿美元。它预计,仅65岁及以上老年人的基因检测机会就约为630亿美元。该公司估计,41岁至65岁成年人的潜在基因检测市场总额约为600亿美元。</blockquote></p><p>Invitae believes that it's at an inflection point in the transformation curve for genetic testing. As the company continues to drive costs lower and expands its menu of tests, it expects testing volumes to increase significantly.</p><p><blockquote>Invitae认为,它正处于基因检测转型曲线的拐点。随着该公司继续降低成本并扩大测试菜单,预计测试量将大幅增加。</blockquote></p><p><b>Better than Tesla?</b></p><p><blockquote><b>比特斯拉好?</b></blockquote></p><p>To be sure, Invitae hasn't been as big of a winner as Tesla so far. Over the last five years, thehealthcare stockhas quintupled in value. During the same period, however, Tesla skyrocketed close to 1,500%.</p><p><blockquote>可以肯定的是,到目前为止,Invitae 还没有像特斯拉那样成为大赢家。过去五年,医疗保健股票的价值增长了五倍。然而,在同一时期,特斯拉飙升了近1500%。</blockquote></p><p>But could Invitae be a better pick than Tesla over the long run? When asked in a Bloomberg interview in December which stock could fuel the biggest gains for ARK ETFs over the next five years, Wood acknowledged that Tesla is in the running. However, she also stated, \"The biggest upside surprises are going to come from the genomics space.\"</p><p><blockquote>但从长远来看,Invitae会是比特斯拉更好的选择吗?当在去年 12 月接受彭博社采访时被问及哪只股票可以推动 ARK ETF 在未来五年内实现最大涨幅时,伍德承认特斯拉正在竞选之中。然而,她也表示,“最大的惊喜将来自基因组学领域。”</blockquote></p><p>That doesn't mean Invitae is necessarily the genomics stock that will emerge as the major surprise winner of the future. It could be, though.</p><p><blockquote>这并不意味着 Invitae 一定是基因组学股票,将成为未来的主要惊喜赢家。不过,也有可能。</blockquote></p><p>The company's market cap currently stands at only around $8.5 billion. Invitae could potentially be a 10-bagger if it snags a double-digit share of its addressable market. While Tesla has been remarkably successful, it's a stretch to envision the stock becoming a 10-bagger again.</p><p><blockquote>该公司目前的市值仅为85亿美元左右。如果 Invitae 在其潜在市场中占据两位数的份额,它可能会成为一个 10 袋生产商。虽然特斯拉取得了巨大成功,但很难想象该股再次成为 10 袋股票。</blockquote></p><p>Invitae just might be a better buy than Tesla right now. Even if it's not, though, there's a really good chance the stock won't remain underappreciated for too much longer.</p><p><blockquote>Invitae 目前可能比特斯拉更值得购买。不过,即使事实并非如此,该股也很有可能不会在更长时间内保持低估状态。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.fool.com/investing/2021/03/19/is-this-underappreciated-cathie-wood-stock-a-bette/\">Motley Fool</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/03/19/is-this-underappreciated-cathie-wood-stock-a-bette/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197074607","content_text":"It definitely could have more upside potential.Pretty much everybody knows Cathie Wood really likesTesla(NASDAQ:TSLA). The ARK Investment Management founder and CEO talks about Tesla regularly. And when the electric-vehicle stock dips, Wood usually buys even more for her high-flying exchange-traded funds.Many of the other holdings in the ETFs managed by Wood don't receive as much attention. However, she pointed to one of them earlier this month in a CNBC interview, referring to it as one of the \"most underappreciated\" stocks that she owns.What is this underappreciated stock -- and could it be an even better buy than Tesla?It's in the genesWood singled out medical genetics leaderInvitae(NYSE:NVTA)as an especially underappreciated stock. The company states that its mission \"is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.\"That's the kind of ambitious goal that excites Cathie Wood. It's not surprising, therefore, that two of the ETFs that she manages have positions in Invitae. The stock is the 11th-largest holding in theARK Innovation ETFand the 17th-largest holding in theARK Genomic Revolution ETF.Invitae offers a wide range of genetic testing. Individuals can determine their risks of passing on genetic conditions to children and the most suitable embryos to help ensure a healthy pregnancy can be identified during in vitro fertilization. Healthcare providers can order genetic diagnostics tests for an extensive and growing list of conditions.Over the last five years, Invitae's trailing-12-month revenue has skyrocketed over 2,400%. That performance trounces Tesla's revenue growth of around 640% during the same period.Unlike Tesla, however, Invitae isn't profitable yet. But the genetic testing companyhas a path to profitabilityover the next few years, especially with the recent acquisitions of ArcherDX and One Codex expanding Invitae's capabilities.A massive potential marketIn the past, the high costs of genetic testing served as a limiting factor for growth in the market. But technological innovations in gene sequencing have reduced the costs of testing and opened the door to a massive potential market.Invitae CEO Sean George told CNBC last week that the scenario for genetic testing is similar to what happened in the computing and networking industry around four decades ago. Lower semiconductor costs back then set the stage for an explosion in the market.How big could the explosion be in genetic testing? Invitae thinks that its total addressable market tops $150 billion annually. It projects that the genetic testing opportunity in senior adults ages 65 and over alone is around $63 billion. The company estimates that the potential genetic-testing market in adults between the ages of 41 and 65 totals around $60 billion.Invitae believes that it's at an inflection point in the transformation curve for genetic testing. As the company continues to drive costs lower and expands its menu of tests, it expects testing volumes to increase significantly.Better than Tesla?To be sure, Invitae hasn't been as big of a winner as Tesla so far. Over the last five years, thehealthcare stockhas quintupled in value. During the same period, however, Tesla skyrocketed close to 1,500%.But could Invitae be a better pick than Tesla over the long run? When asked in a Bloomberg interview in December which stock could fuel the biggest gains for ARK ETFs over the next five years, Wood acknowledged that Tesla is in the running. However, she also stated, \"The biggest upside surprises are going to come from the genomics space.\"That doesn't mean Invitae is necessarily the genomics stock that will emerge as the major surprise winner of the future. It could be, though.The company's market cap currently stands at only around $8.5 billion. Invitae could potentially be a 10-bagger if it snags a double-digit share of its addressable market. While Tesla has been remarkably successful, it's a stretch to envision the stock becoming a 10-bagger again.Invitae just might be a better buy than Tesla right now. Even if it's not, though, there's a really good chance the stock won't remain underappreciated for too much longer.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":899,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":851090164,"gmtCreate":1634857328674,"gmtModify":1634857328782,"author":{"id":"3576884931619523","authorId":"3576884931619523","name":"ikarishingi","avatar":"https://static.tigerbbs.com/3d2e9e96320a649321b1565cb688a7dd","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576884931619523","idStr":"3576884931619523"},"themes":[],"title":"","htmlText":"What a drastic droo","listText":"What a drastic droo","text":"What a drastic droo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/851090164","repostId":"2177640184","repostType":4,"isVote":1,"tweetType":1,"viewCount":592,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":858088875,"gmtCreate":1634953290793,"gmtModify":1634954241447,"author":{"id":"3576884931619523","authorId":"3576884931619523","name":"ikarishingi","avatar":"https://static.tigerbbs.com/3d2e9e96320a649321b1565cb688a7dd","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576884931619523","idStr":"3576884931619523"},"themes":[],"title":"","htmlText":"Tesla to the moon","listText":"Tesla to the moon","text":"Tesla to the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/858088875","repostId":"1166213725","repostType":4,"repost":{"id":"1166213725","kind":"news","pubTimestamp":1634948473,"share":"https://www.laohunote.com/m/news/1166213725?lang=zh_CN&edition=full","pubTime":"2021-10-23 08:21","market":"us","language":"en","title":"Tesla Stock Closed Above $900 for First Time. What Could Come Next.<blockquote>特斯拉股价首次收于 900 美元以上。接下来会发生什么。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1166213725","media":"Barrons","summary":"Tesla stock hit a new all-time high in Friday trading, and closed at a record. The stock’s recent run has been incredible. How high can it go?Tesla stock closed at $909.68, up about 1.8%. The S&P 500 dropped about 0.1%, while the Dow Jones Industrial Average added about 0.2%.Shares of the electric-vehicle giant have been boosted by strong deliveries and earnings. Shares also got a boost Friday from a credit upgrade at S&P. Tesla debt is now BB+ rated, one notch below investment grade.Tesla stoc","content":"<p>Tesla stock hit a new all-time high in Friday trading, and closed at a record. The stock’s recent run has been incredible. How high can it go?</p><p><blockquote>特斯拉股价在周五交易中创下历史新高,并以历史新高收盘。该股最近的表现令人难以置信。能升到多高?</blockquote></p><p> Tesla (ticker: TSLA) stock closed at $909.68, up about 1.8%. The S&P 500 dropped about 0.1%, while the Dow Jones Industrial Average added about 0.2%.</p><p><blockquote>特斯拉(股票代码:TSLA)股价收于909.68美元,上涨约1.8%。标普500下跌约0.1%,道琼斯工业平均指数上涨约0.2%。</blockquote></p><p> Shares of the electric-vehicle giant have been boosted by strong deliveries and earnings. Shares also got a boost Friday from a credit upgrade at S&P. Tesla debt is now BB+ rated, one notch below investment grade.</p><p><blockquote>强劲的交付量和盈利提振了这家电动汽车巨头的股价。周五,标准普尔信用评级上调也提振了股价。特斯拉债务目前的评级为 BB+,比投资级别低一级。</blockquote></p><p> Tesla stock’s new 52-week intraday high is $910 on the nose. The old high-water mark of $900.40 was set on Jan. 25, according to Dow Jones Market Data. On Thursday, Tesla closed at a record for the first time since Jan. 26.</p><p><blockquote>特斯拉股市盘中新高 910 美元即将创下 52 周新高。根据道琼斯市场数据,900.40美元的旧高点是在1月25日创下的。周四,特斯拉自1月26日以来首次创下历史新高。</blockquote></p><p> Shares are up about 40% over the past three months, pushing the market cap to roughly $910 billion. (Tesla has about 1 billion shares outstanding, making the math easy.)</p><p><blockquote>过去三个月,该股上涨了约 40%,市值达到约 9,100 亿美元。(特斯拉约有 10 亿股流通股,计算起来很容易。)</blockquote></p><p> Bulls, naturally, see more gains ahead. Wedbush analyst Dan Ives raised his bull-case Tesla stock price target to $1,500 from $1,300 after the company reported better-than-expected earnings on Wednesday.</p><p><blockquote>多头自然会看到更多涨幅。Wedbush 分析师 Dan Ives 将特斯拉股价目标从 1,300 美元上调至 1,500 美元,此前该公司周三公布了好于预期的收益。</blockquote></p><p> “Tesla is rising because earnings revisions are soaring,” points out Gary Black, managing partner of the Future Fund Active exchange-traded fund. Analyst estimates for Tesla’s 2022 earnings have risen to about $8 a share from $6 over the past few weeks. “Rising estimates drove Tesla to the moon in 2020. They will drive Tesla to $1,000-plus in 2022,” Black says.</p><p><blockquote>“Future Fund Active exchange-traded Fund 的执行合伙人 Gary Black 指出:”特斯拉之所以上升,是因为盈利修正幅度在飙升。过去几周,分析师对特斯拉 2022 年盈利的预期已从每股 6 美元上升到约 8 美元。“不断上升的估计将特斯拉推上了 2020 年的月球。它们将推动特斯拉在 2022 年达到 1000 美元以上,”布莱克说。</blockquote></p><p> Ives rates Tesla stock Buy, and Tesla is the largest position in Black’s fund.</p><p><blockquote>艾夫斯将特斯拉股票评级为买入,特斯拉是布莱克基金中最大的仓位。</blockquote></p><p> Yes, there are still Tesla bears out there who believe the stock is overvalued. The bottom third of analyst price targets averages about $425, less than half of Friday’s close.</p><p><blockquote>是的,仍然有特斯拉空头认为该股被高估了。分析师目标价的倒数三分之一平均约为 425 美元,不到周五收盘价的一半。</blockquote></p><p> Bears expect the sky-high valuation to give investors pause eventually. Stocks don’t usually fall just because investors, collectively, wake up one morning and feel differently about valuation. Something has to happen. The overall market could tumble, or the business could trip up. Analysts expect Tesla deliveries to grow to 1.3 million units in 2022 from about 890,000 units in 2021. Any hiccup to growth would be a negative catalyst for shares.</p><p><blockquote>看空者预计天价估值最终会让投资者犹豫不决。股票下跌通常不会仅仅因为投资者一天早上醒来对估值有不同的看法。总得有点事发生。整体市场可能会暴跌,或者业务可能会陷入困境。分析师预计特斯拉交付量将从 2021 年的约 89 万辆增长至 2022 年的 130 万辆。增长的任何挫折都将成为股市的负面催化剂。</blockquote></p><p> Whether the stock rises or falls in the short run is anyone’s guess. For now, though, the momentum belongs to Tesla bulls.</p><p><blockquote>该股短期内是上涨还是下跌谁也说不准。不过,就目前而言,势头属于特斯拉多头。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Stock Closed Above $900 for First Time. What Could Come Next.<blockquote>特斯拉股价首次收于 900 美元以上。接下来会发生什么。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Stock Closed Above $900 for First Time. What Could Come Next.<blockquote>特斯拉股价首次收于 900 美元以上。接下来会发生什么。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-10-23 08:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Tesla stock hit a new all-time high in Friday trading, and closed at a record. The stock’s recent run has been incredible. How high can it go?</p><p><blockquote>特斯拉股价在周五交易中创下历史新高,并以历史新高收盘。该股最近的表现令人难以置信。能升到多高?</blockquote></p><p> Tesla (ticker: TSLA) stock closed at $909.68, up about 1.8%. The S&P 500 dropped about 0.1%, while the Dow Jones Industrial Average added about 0.2%.</p><p><blockquote>特斯拉(股票代码:TSLA)股价收于909.68美元,上涨约1.8%。标普500下跌约0.1%,道琼斯工业平均指数上涨约0.2%。</blockquote></p><p> Shares of the electric-vehicle giant have been boosted by strong deliveries and earnings. Shares also got a boost Friday from a credit upgrade at S&P. Tesla debt is now BB+ rated, one notch below investment grade.</p><p><blockquote>强劲的交付量和盈利提振了这家电动汽车巨头的股价。周五,标准普尔信用评级上调也提振了股价。特斯拉债务目前的评级为 BB+,比投资级别低一级。</blockquote></p><p> Tesla stock’s new 52-week intraday high is $910 on the nose. The old high-water mark of $900.40 was set on Jan. 25, according to Dow Jones Market Data. On Thursday, Tesla closed at a record for the first time since Jan. 26.</p><p><blockquote>特斯拉股市盘中新高 910 美元即将创下 52 周新高。根据道琼斯市场数据,900.40美元的旧高点是在1月25日创下的。周四,特斯拉自1月26日以来首次创下历史新高。</blockquote></p><p> Shares are up about 40% over the past three months, pushing the market cap to roughly $910 billion. (Tesla has about 1 billion shares outstanding, making the math easy.)</p><p><blockquote>过去三个月,该股上涨了约 40%,市值达到约 9,100 亿美元。(特斯拉约有 10 亿股流通股,计算起来很容易。)</blockquote></p><p> Bulls, naturally, see more gains ahead. Wedbush analyst Dan Ives raised his bull-case Tesla stock price target to $1,500 from $1,300 after the company reported better-than-expected earnings on Wednesday.</p><p><blockquote>多头自然会看到更多涨幅。Wedbush 分析师 Dan Ives 将特斯拉股价目标从 1,300 美元上调至 1,500 美元,此前该公司周三公布了好于预期的收益。</blockquote></p><p> “Tesla is rising because earnings revisions are soaring,” points out Gary Black, managing partner of the Future Fund Active exchange-traded fund. Analyst estimates for Tesla’s 2022 earnings have risen to about $8 a share from $6 over the past few weeks. “Rising estimates drove Tesla to the moon in 2020. They will drive Tesla to $1,000-plus in 2022,” Black says.</p><p><blockquote>“Future Fund Active exchange-traded Fund 的执行合伙人 Gary Black 指出:”特斯拉之所以上升,是因为盈利修正幅度在飙升。过去几周,分析师对特斯拉 2022 年盈利的预期已从每股 6 美元上升到约 8 美元。“不断上升的估计将特斯拉推上了 2020 年的月球。它们将推动特斯拉在 2022 年达到 1000 美元以上,”布莱克说。</blockquote></p><p> Ives rates Tesla stock Buy, and Tesla is the largest position in Black’s fund.</p><p><blockquote>艾夫斯将特斯拉股票评级为买入,特斯拉是布莱克基金中最大的仓位。</blockquote></p><p> Yes, there are still Tesla bears out there who believe the stock is overvalued. The bottom third of analyst price targets averages about $425, less than half of Friday’s close.</p><p><blockquote>是的,仍然有特斯拉空头认为该股被高估了。分析师目标价的倒数三分之一平均约为 425 美元,不到周五收盘价的一半。</blockquote></p><p> Bears expect the sky-high valuation to give investors pause eventually. Stocks don’t usually fall just because investors, collectively, wake up one morning and feel differently about valuation. Something has to happen. The overall market could tumble, or the business could trip up. Analysts expect Tesla deliveries to grow to 1.3 million units in 2022 from about 890,000 units in 2021. Any hiccup to growth would be a negative catalyst for shares.</p><p><blockquote>看空者预计天价估值最终会让投资者犹豫不决。股票下跌通常不会仅仅因为投资者一天早上醒来对估值有不同的看法。总得有点事发生。整体市场可能会暴跌,或者业务可能会陷入困境。分析师预计特斯拉交付量将从 2021 年的约 89 万辆增长至 2022 年的 130 万辆。增长的任何挫折都将成为股市的负面催化剂。</blockquote></p><p> Whether the stock rises or falls in the short run is anyone’s guess. For now, though, the momentum belongs to Tesla bulls.</p><p><blockquote>该股短期内是上涨还是下跌谁也说不准。不过,就目前而言,势头属于特斯拉多头。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.barrons.com/articles/tesla-stock-record-high-51634913773?mod=hp_LATEST\">Barrons</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.barrons.com/articles/tesla-stock-record-high-51634913773?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166213725","content_text":"Tesla stock hit a new all-time high in Friday trading, and closed at a record. The stock’s recent run has been incredible. How high can it go?\nTesla (ticker: TSLA) stock closed at $909.68, up about 1.8%. The S&P 500 dropped about 0.1%, while the Dow Jones Industrial Average added about 0.2%.\nShares of the electric-vehicle giant have been boosted by strong deliveries and earnings. Shares also got a boost Friday from a credit upgrade at S&P. Tesla debt is now BB+ rated, one notch below investment grade.\nTesla stock’s new 52-week intraday high is $910 on the nose. The old high-water mark of $900.40 was set on Jan. 25, according to Dow Jones Market Data. On Thursday, Tesla closed at a record for the first time since Jan. 26.\nShares are up about 40% over the past three months, pushing the market cap to roughly $910 billion. (Tesla has about 1 billion shares outstanding, making the math easy.)\nBulls, naturally, see more gains ahead. Wedbush analyst Dan Ives raised his bull-case Tesla stock price target to $1,500 from $1,300 after the company reported better-than-expected earnings on Wednesday.\n“Tesla is rising because earnings revisions are soaring,” points out Gary Black, managing partner of the Future Fund Active exchange-traded fund. Analyst estimates for Tesla’s 2022 earnings have risen to about $8 a share from $6 over the past few weeks. “Rising estimates drove Tesla to the moon in 2020. They will drive Tesla to $1,000-plus in 2022,” Black says.\nIves rates Tesla stock Buy, and Tesla is the largest position in Black’s fund.\nYes, there are still Tesla bears out there who believe the stock is overvalued. The bottom third of analyst price targets averages about $425, less than half of Friday’s close.\nBears expect the sky-high valuation to give investors pause eventually. Stocks don’t usually fall just because investors, collectively, wake up one morning and feel differently about valuation. Something has to happen. The overall market could tumble, or the business could trip up. Analysts expect Tesla deliveries to grow to 1.3 million units in 2022 from about 890,000 units in 2021. Any hiccup to growth would be a negative catalyst for shares.\nWhether the stock rises or falls in the short run is anyone’s guess. For now, though, the momentum belongs to Tesla bulls.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":648,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":350945833,"gmtCreate":1616155073822,"gmtModify":1634526972633,"author":{"id":"3576884931619523","authorId":"3576884931619523","name":"ikarishingi","avatar":"https://static.tigerbbs.com/3d2e9e96320a649321b1565cb688a7dd","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576884931619523","idStr":"3576884931619523"},"themes":[],"title":"","htmlText":"Tesla to the moon","listText":"Tesla to the moon","text":"Tesla to the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/350945833","repostId":"1197074607","repostType":4,"repost":{"id":"1197074607","kind":"news","pubTimestamp":1616152229,"share":"https://www.laohunote.com/m/news/1197074607?lang=zh_CN&edition=full","pubTime":"2021-03-19 19:10","market":"us","language":"en","title":"Is This Underappreciated Cathie Wood Stock a Better Buy Than Tesla Right Now?<blockquote>这只被低估的凯西伍德股票现在比特斯拉更值得购买吗?</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1197074607","media":"Motley Fool","summary":"It definitely could have more upside potential.Pretty much everybody knows Cathie Wood really likesT","content":"<p>It definitely could have more upside potential.Pretty much everybody knows Cathie Wood really likes<b>Tesla</b>(NASDAQ:TSLA). The ARK Investment Management founder and CEO talks about Tesla regularly. And when the electric-vehicle stock dips, Wood usually buys even more for her high-flying exchange-traded funds.</p><p><blockquote>它肯定有更多的上涨潜力。几乎每个人都知道凯茜·伍德真的很喜欢<b>特斯拉</b>(纳斯达克股票代码:TSLA)方舟投资管理公司的创始人兼首席执行官经常谈论特斯拉。当电动汽车股票下跌时,伍德通常会为她飞涨的交易所交易基金买入更多。</blockquote></p><p>Many of the other holdings in the ETFs managed by Wood don't receive as much attention. However, she pointed to one of them earlier this month in a CNBC interview, referring to it as one of the \"most underappreciated\" stocks that she owns.</p><p><blockquote>伍德管理的 ETF 中的许多其他持股并没有受到太多关注。然而,她在本月早些时候接受 CNBC 采访时指出了其中一只股票,称其为她拥有的“最被低估”的股票之一。</blockquote></p><p>What is this underappreciated stock -- and could it be an even better buy than Tesla?</p><p><blockquote>这只被低估的股票是什么——它会比特斯拉更值得购买吗?</blockquote></p><p><b>It's in the genes</b></p><p><blockquote><b>这是基因里的</b></blockquote></p><p>Wood singled out medical genetics leader<b>Invitae</b>(NYSE:NVTA)as an especially underappreciated stock. The company states that its mission \"is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.\"</p><p><blockquote>伍德挑选出医学遗传学领导者<b>邀请</b>(纽约证券交易所股票代码:NVTA)作为一只特别被低估的股票。该公司表示,其使命“是将全面的基因信息引入主流医学,以改善数十亿人的医疗保健。”</blockquote></p><p>That's the kind of ambitious goal that excites Cathie Wood. It's not surprising, therefore, that two of the ETFs that she manages have positions in Invitae. The stock is the 11th-largest holding in the<b>ARK Innovation ETF</b>and the 17th-largest holding in the<b>ARK Genomic Revolution ETF</b>.</p><p><blockquote>这就是让凯西·伍德兴奋的雄心勃勃的目标。因此,她管理的两只 ETF 持有 Invitae 头寸也就不足为奇了。该股是美国第 11 大持股<b>方舟创新ETF</b>以及第 17 大持股<b>方舟基因组革命 ETF</b>.</blockquote></p><p>Invitae offers a wide range of genetic testing. Individuals can determine their risks of passing on genetic conditions to children and the most suitable embryos to help ensure a healthy pregnancy can be identified during in vitro fertilization. Healthcare providers can order genetic diagnostics tests for an extensive and growing list of conditions.</p><p><blockquote>Invitae提供广泛的基因检测。个人可以确定他们将遗传疾病传递给孩子的风险,并在体外受精期间确定最合适的胚胎,以帮助确保健康怀孕。医疗保健提供者可以为越来越多的疾病订购基因诊断测试。</blockquote></p><p>Over the last five years, Invitae's trailing-12-month revenue has skyrocketed over 2,400%. That performance trounces Tesla's revenue growth of around 640% during the same period.</p><p><blockquote>在过去五年中,Invitae 过去 12 个月的收入飙升了 2,400% 以上。这一业绩超过了特斯拉同期约 640% 的收入增长。</blockquote></p><p>Unlike Tesla, however, Invitae isn't profitable yet. But the genetic testing companyhas a path to profitabilityover the next few years, especially with the recent acquisitions of ArcherDX and One Codex expanding Invitae's capabilities.</p><p><blockquote>然而,与特斯拉不同的是,Invitae 尚未盈利。但这家基因检测公司在未来几年有一条实现盈利的道路,特别是最近收购了 ArcherDX 和 One Codex 扩展了 Invitae 的能力。</blockquote></p><p><b>A massive potential market</b></p><p><blockquote><b>巨大的潜在市场</b></blockquote></p><p>In the past, the high costs of genetic testing served as a limiting factor for growth in the market. But technological innovations in gene sequencing have reduced the costs of testing and opened the door to a massive potential market.</p><p><blockquote>过去,基因检测的高昂成本是市场增长的限制因素。但基因测序的技术创新降低了检测成本,并为巨大的潜在市场打开了大门。</blockquote></p><p>Invitae CEO Sean George told CNBC last week that the scenario for genetic testing is similar to what happened in the computing and networking industry around four decades ago. Lower semiconductor costs back then set the stage for an explosion in the market.</p><p><blockquote>Invitae 首席执行官肖恩·乔治 (Sean George) 上周告诉 CNBC,基因检测的场景与大约四十年前计算和网络行业发生的情况类似。半导体成本的下降为市场的爆炸式增长奠定了基础。</blockquote></p><p>How big could the explosion be in genetic testing? Invitae thinks that its total addressable market tops $150 billion annually. It projects that the genetic testing opportunity in senior adults ages 65 and over alone is around $63 billion. The company estimates that the potential genetic-testing market in adults between the ages of 41 and 65 totals around $60 billion.</p><p><blockquote>基因检测的爆炸会有多大?Invitae 认为其潜在市场总额每年超过 1500 亿美元。它预计,仅65岁及以上老年人的基因检测机会就约为630亿美元。该公司估计,41岁至65岁成年人的潜在基因检测市场总额约为600亿美元。</blockquote></p><p>Invitae believes that it's at an inflection point in the transformation curve for genetic testing. As the company continues to drive costs lower and expands its menu of tests, it expects testing volumes to increase significantly.</p><p><blockquote>Invitae认为,它正处于基因检测转型曲线的拐点。随着该公司继续降低成本并扩大测试菜单,预计测试量将大幅增加。</blockquote></p><p><b>Better than Tesla?</b></p><p><blockquote><b>比特斯拉好?</b></blockquote></p><p>To be sure, Invitae hasn't been as big of a winner as Tesla so far. Over the last five years, thehealthcare stockhas quintupled in value. During the same period, however, Tesla skyrocketed close to 1,500%.</p><p><blockquote>可以肯定的是,到目前为止,Invitae 还没有像特斯拉那样成为大赢家。过去五年,医疗保健股票的价值增长了五倍。然而,在同一时期,特斯拉飙升了近1500%。</blockquote></p><p>But could Invitae be a better pick than Tesla over the long run? When asked in a Bloomberg interview in December which stock could fuel the biggest gains for ARK ETFs over the next five years, Wood acknowledged that Tesla is in the running. However, she also stated, \"The biggest upside surprises are going to come from the genomics space.\"</p><p><blockquote>但从长远来看,Invitae会是比特斯拉更好的选择吗?当在去年 12 月接受彭博社采访时被问及哪只股票可以推动 ARK ETF 在未来五年内实现最大涨幅时,伍德承认特斯拉正在竞选之中。然而,她也表示,“最大的惊喜将来自基因组学领域。”</blockquote></p><p>That doesn't mean Invitae is necessarily the genomics stock that will emerge as the major surprise winner of the future. It could be, though.</p><p><blockquote>这并不意味着 Invitae 一定是基因组学股票,将成为未来的主要惊喜赢家。不过,也有可能。</blockquote></p><p>The company's market cap currently stands at only around $8.5 billion. Invitae could potentially be a 10-bagger if it snags a double-digit share of its addressable market. While Tesla has been remarkably successful, it's a stretch to envision the stock becoming a 10-bagger again.</p><p><blockquote>该公司目前的市值仅为85亿美元左右。如果 Invitae 在其潜在市场中占据两位数的份额,它可能会成为一个 10 袋生产商。虽然特斯拉取得了巨大成功,但很难想象该股再次成为 10 袋股票。</blockquote></p><p>Invitae just might be a better buy than Tesla right now. Even if it's not, though, there's a really good chance the stock won't remain underappreciated for too much longer.</p><p><blockquote>Invitae 目前可能比特斯拉更值得购买。不过,即使事实并非如此,该股也很有可能不会在更长时间内保持低估状态。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is This Underappreciated Cathie Wood Stock a Better Buy Than Tesla Right Now?<blockquote>这只被低估的凯西伍德股票现在比特斯拉更值得购买吗?</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs This Underappreciated Cathie Wood Stock a Better Buy Than Tesla Right Now?<blockquote>这只被低估的凯西伍德股票现在比特斯拉更值得购买吗?</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-03-19 19:10</span>\n</p>\n</h4>\n</header>\n<article>\n<p>It definitely could have more upside potential.Pretty much everybody knows Cathie Wood really likes<b>Tesla</b>(NASDAQ:TSLA). The ARK Investment Management founder and CEO talks about Tesla regularly. And when the electric-vehicle stock dips, Wood usually buys even more for her high-flying exchange-traded funds.</p><p><blockquote>它肯定有更多的上涨潜力。几乎每个人都知道凯茜·伍德真的很喜欢<b>特斯拉</b>(纳斯达克股票代码:TSLA)方舟投资管理公司的创始人兼首席执行官经常谈论特斯拉。当电动汽车股票下跌时,伍德通常会为她飞涨的交易所交易基金买入更多。</blockquote></p><p>Many of the other holdings in the ETFs managed by Wood don't receive as much attention. However, she pointed to one of them earlier this month in a CNBC interview, referring to it as one of the \"most underappreciated\" stocks that she owns.</p><p><blockquote>伍德管理的 ETF 中的许多其他持股并没有受到太多关注。然而,她在本月早些时候接受 CNBC 采访时指出了其中一只股票,称其为她拥有的“最被低估”的股票之一。</blockquote></p><p>What is this underappreciated stock -- and could it be an even better buy than Tesla?</p><p><blockquote>这只被低估的股票是什么——它会比特斯拉更值得购买吗?</blockquote></p><p><b>It's in the genes</b></p><p><blockquote><b>这是基因里的</b></blockquote></p><p>Wood singled out medical genetics leader<b>Invitae</b>(NYSE:NVTA)as an especially underappreciated stock. The company states that its mission \"is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.\"</p><p><blockquote>伍德挑选出医学遗传学领导者<b>邀请</b>(纽约证券交易所股票代码:NVTA)作为一只特别被低估的股票。该公司表示,其使命“是将全面的基因信息引入主流医学,以改善数十亿人的医疗保健。”</blockquote></p><p>That's the kind of ambitious goal that excites Cathie Wood. It's not surprising, therefore, that two of the ETFs that she manages have positions in Invitae. The stock is the 11th-largest holding in the<b>ARK Innovation ETF</b>and the 17th-largest holding in the<b>ARK Genomic Revolution ETF</b>.</p><p><blockquote>这就是让凯西·伍德兴奋的雄心勃勃的目标。因此,她管理的两只 ETF 持有 Invitae 头寸也就不足为奇了。该股是美国第 11 大持股<b>方舟创新ETF</b>以及第 17 大持股<b>方舟基因组革命 ETF</b>.</blockquote></p><p>Invitae offers a wide range of genetic testing. Individuals can determine their risks of passing on genetic conditions to children and the most suitable embryos to help ensure a healthy pregnancy can be identified during in vitro fertilization. Healthcare providers can order genetic diagnostics tests for an extensive and growing list of conditions.</p><p><blockquote>Invitae提供广泛的基因检测。个人可以确定他们将遗传疾病传递给孩子的风险,并在体外受精期间确定最合适的胚胎,以帮助确保健康怀孕。医疗保健提供者可以为越来越多的疾病订购基因诊断测试。</blockquote></p><p>Over the last five years, Invitae's trailing-12-month revenue has skyrocketed over 2,400%. That performance trounces Tesla's revenue growth of around 640% during the same period.</p><p><blockquote>在过去五年中,Invitae 过去 12 个月的收入飙升了 2,400% 以上。这一业绩超过了特斯拉同期约 640% 的收入增长。</blockquote></p><p>Unlike Tesla, however, Invitae isn't profitable yet. But the genetic testing companyhas a path to profitabilityover the next few years, especially with the recent acquisitions of ArcherDX and One Codex expanding Invitae's capabilities.</p><p><blockquote>然而,与特斯拉不同的是,Invitae 尚未盈利。但这家基因检测公司在未来几年有一条实现盈利的道路,特别是最近收购了 ArcherDX 和 One Codex 扩展了 Invitae 的能力。</blockquote></p><p><b>A massive potential market</b></p><p><blockquote><b>巨大的潜在市场</b></blockquote></p><p>In the past, the high costs of genetic testing served as a limiting factor for growth in the market. But technological innovations in gene sequencing have reduced the costs of testing and opened the door to a massive potential market.</p><p><blockquote>过去,基因检测的高昂成本是市场增长的限制因素。但基因测序的技术创新降低了检测成本,并为巨大的潜在市场打开了大门。</blockquote></p><p>Invitae CEO Sean George told CNBC last week that the scenario for genetic testing is similar to what happened in the computing and networking industry around four decades ago. Lower semiconductor costs back then set the stage for an explosion in the market.</p><p><blockquote>Invitae 首席执行官肖恩·乔治 (Sean George) 上周告诉 CNBC,基因检测的场景与大约四十年前计算和网络行业发生的情况类似。半导体成本的下降为市场的爆炸式增长奠定了基础。</blockquote></p><p>How big could the explosion be in genetic testing? Invitae thinks that its total addressable market tops $150 billion annually. It projects that the genetic testing opportunity in senior adults ages 65 and over alone is around $63 billion. The company estimates that the potential genetic-testing market in adults between the ages of 41 and 65 totals around $60 billion.</p><p><blockquote>基因检测的爆炸会有多大?Invitae 认为其潜在市场总额每年超过 1500 亿美元。它预计,仅65岁及以上老年人的基因检测机会就约为630亿美元。该公司估计,41岁至65岁成年人的潜在基因检测市场总额约为600亿美元。</blockquote></p><p>Invitae believes that it's at an inflection point in the transformation curve for genetic testing. As the company continues to drive costs lower and expands its menu of tests, it expects testing volumes to increase significantly.</p><p><blockquote>Invitae认为,它正处于基因检测转型曲线的拐点。随着该公司继续降低成本并扩大测试菜单,预计测试量将大幅增加。</blockquote></p><p><b>Better than Tesla?</b></p><p><blockquote><b>比特斯拉好?</b></blockquote></p><p>To be sure, Invitae hasn't been as big of a winner as Tesla so far. Over the last five years, thehealthcare stockhas quintupled in value. During the same period, however, Tesla skyrocketed close to 1,500%.</p><p><blockquote>可以肯定的是,到目前为止,Invitae 还没有像特斯拉那样成为大赢家。过去五年,医疗保健股票的价值增长了五倍。然而,在同一时期,特斯拉飙升了近1500%。</blockquote></p><p>But could Invitae be a better pick than Tesla over the long run? When asked in a Bloomberg interview in December which stock could fuel the biggest gains for ARK ETFs over the next five years, Wood acknowledged that Tesla is in the running. However, she also stated, \"The biggest upside surprises are going to come from the genomics space.\"</p><p><blockquote>但从长远来看,Invitae会是比特斯拉更好的选择吗?当在去年 12 月接受彭博社采访时被问及哪只股票可以推动 ARK ETF 在未来五年内实现最大涨幅时,伍德承认特斯拉正在竞选之中。然而,她也表示,“最大的惊喜将来自基因组学领域。”</blockquote></p><p>That doesn't mean Invitae is necessarily the genomics stock that will emerge as the major surprise winner of the future. It could be, though.</p><p><blockquote>这并不意味着 Invitae 一定是基因组学股票,将成为未来的主要惊喜赢家。不过,也有可能。</blockquote></p><p>The company's market cap currently stands at only around $8.5 billion. Invitae could potentially be a 10-bagger if it snags a double-digit share of its addressable market. While Tesla has been remarkably successful, it's a stretch to envision the stock becoming a 10-bagger again.</p><p><blockquote>该公司目前的市值仅为85亿美元左右。如果 Invitae 在其潜在市场中占据两位数的份额,它可能会成为一个 10 袋生产商。虽然特斯拉取得了巨大成功,但很难想象该股再次成为 10 袋股票。</blockquote></p><p>Invitae just might be a better buy than Tesla right now. Even if it's not, though, there's a really good chance the stock won't remain underappreciated for too much longer.</p><p><blockquote>Invitae 目前可能比特斯拉更值得购买。不过,即使事实并非如此,该股也很有可能不会在更长时间内保持低估状态。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.fool.com/investing/2021/03/19/is-this-underappreciated-cathie-wood-stock-a-bette/\">Motley Fool</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/03/19/is-this-underappreciated-cathie-wood-stock-a-bette/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197074607","content_text":"It definitely could have more upside potential.Pretty much everybody knows Cathie Wood really likesTesla(NASDAQ:TSLA). The ARK Investment Management founder and CEO talks about Tesla regularly. And when the electric-vehicle stock dips, Wood usually buys even more for her high-flying exchange-traded funds.Many of the other holdings in the ETFs managed by Wood don't receive as much attention. However, she pointed to one of them earlier this month in a CNBC interview, referring to it as one of the \"most underappreciated\" stocks that she owns.What is this underappreciated stock -- and could it be an even better buy than Tesla?It's in the genesWood singled out medical genetics leaderInvitae(NYSE:NVTA)as an especially underappreciated stock. The company states that its mission \"is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.\"That's the kind of ambitious goal that excites Cathie Wood. It's not surprising, therefore, that two of the ETFs that she manages have positions in Invitae. The stock is the 11th-largest holding in theARK Innovation ETFand the 17th-largest holding in theARK Genomic Revolution ETF.Invitae offers a wide range of genetic testing. Individuals can determine their risks of passing on genetic conditions to children and the most suitable embryos to help ensure a healthy pregnancy can be identified during in vitro fertilization. Healthcare providers can order genetic diagnostics tests for an extensive and growing list of conditions.Over the last five years, Invitae's trailing-12-month revenue has skyrocketed over 2,400%. That performance trounces Tesla's revenue growth of around 640% during the same period.Unlike Tesla, however, Invitae isn't profitable yet. But the genetic testing companyhas a path to profitabilityover the next few years, especially with the recent acquisitions of ArcherDX and One Codex expanding Invitae's capabilities.A massive potential marketIn the past, the high costs of genetic testing served as a limiting factor for growth in the market. But technological innovations in gene sequencing have reduced the costs of testing and opened the door to a massive potential market.Invitae CEO Sean George told CNBC last week that the scenario for genetic testing is similar to what happened in the computing and networking industry around four decades ago. Lower semiconductor costs back then set the stage for an explosion in the market.How big could the explosion be in genetic testing? Invitae thinks that its total addressable market tops $150 billion annually. It projects that the genetic testing opportunity in senior adults ages 65 and over alone is around $63 billion. The company estimates that the potential genetic-testing market in adults between the ages of 41 and 65 totals around $60 billion.Invitae believes that it's at an inflection point in the transformation curve for genetic testing. As the company continues to drive costs lower and expands its menu of tests, it expects testing volumes to increase significantly.Better than Tesla?To be sure, Invitae hasn't been as big of a winner as Tesla so far. Over the last five years, thehealthcare stockhas quintupled in value. During the same period, however, Tesla skyrocketed close to 1,500%.But could Invitae be a better pick than Tesla over the long run? When asked in a Bloomberg interview in December which stock could fuel the biggest gains for ARK ETFs over the next five years, Wood acknowledged that Tesla is in the running. However, she also stated, \"The biggest upside surprises are going to come from the genomics space.\"That doesn't mean Invitae is necessarily the genomics stock that will emerge as the major surprise winner of the future. It could be, though.The company's market cap currently stands at only around $8.5 billion. Invitae could potentially be a 10-bagger if it snags a double-digit share of its addressable market. While Tesla has been remarkably successful, it's a stretch to envision the stock becoming a 10-bagger again.Invitae just might be a better buy than Tesla right now. Even if it's not, though, there's a really good chance the stock won't remain underappreciated for too much longer.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":899,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}